These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30819074)

  • 1. Investigation of Potential Paraoxonase-I Inhibitors by Kinetic and Molecular Docking Studies: Chemotherapeutic Drugs.
    Türkeş C
    Protein Pept Lett; 2019; 26(6):392-402. PubMed ID: 30819074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Human Serum Paraoxonase-I with Antimycotic Drugs: In Vitro and In Silico Studies.
    Türkeş C; Beydemir Ş
    Appl Biochem Biotechnol; 2020 Jan; 190(1):252-269. PubMed ID: 31342307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Docking Studies and Inhibition Properties of Some Antineoplastic Agents against Paraoxonase-I.
    Demir Y; Türkeş C; Beydemir Ş
    Anticancer Agents Med Chem; 2020; 20(7):887-896. PubMed ID: 32067621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the inhibitory effects and molecular docking of some sulfonamides on human serum paraoxonase 1.
    Alim Z; Kilic D; Koksal Z; Beydemir S; Ozdemir H
    J Biochem Mol Toxicol; 2017 Oct; 31(10):. PubMed ID: 28665493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-based contrast agents:
    Beydemir Ş; Türkeş C; Yalçın A
    Drug Chem Toxicol; 2021 Sep; 44(5):508-517. PubMed ID: 31179770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some indazoles reduced the activity of human serum paraoxonase 1, an antioxidant enzyme:
    Alım Z; Kılıç D; Demir Y
    Arch Physiol Biochem; 2019 Dec; 125(5):387-395. PubMed ID: 29741961
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro effects of thirty-eight cardiac drugs on human serum paraoxonase.
    Argan O; Cikrikci K; Uslu H; Gencer N
    Chem Biol Drug Des; 2022 Jul; 100(1):80-89. PubMed ID: 35395139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity.
    Avcikurt AS; Sinan S; Kockar F
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):245-9. PubMed ID: 24934243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum.
    Işgör MM; Beydemir S
    Eur J Pharmacol; 2010 Oct; 645(1-3):135-42. PubMed ID: 20670621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of human serum paraoxonase-1 with some respiratory drugs.
    Gökçe B; Sarıoğlu N; Gençer N; Arslan O
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22407. PubMed ID: 31581362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some calcium-channel blockers: kinetic and
    Türkeş C; Demir Y; Beydemir Ş
    J Biomol Struct Dyn; 2022 Jan; 40(1):77-85. PubMed ID: 32783605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics Used in Patients after Surgery and Effects of Human Serum Paraoxonase-I (PON1) Enzyme Activity.
    Yılmaz A; Dilek E
    Protein Pept Lett; 2019; 26(3):215-220. PubMed ID: 30678610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some coumarins and benzoxazinones as potent paraoxonase 1 inhibitors.
    Karataş MO; Uslu H; Alıcı B; Gökçe B; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1386-91. PubMed ID: 26887799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative purification method for human serum paraoxonase 1 and its interaction with methidathion.
    Gençer N; Yavuz E
    Arch Physiol Biochem; 2017 Jul; 123(3):159-164. PubMed ID: 28276711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies.
    Işık M; Beydemir Ş; Demir Y; Durgun M; Türkeş C; Nasır A; Necip A; Akkuş M
    Int J Biol Macromol; 2020 Mar; 146():1111-1123. PubMed ID: 31739032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics.
    Sinan S; Kockar F; Arslan O
    Biochimie; 2006 May; 88(5):565-74. PubMed ID: 16600468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo.
    Sinan S; Kockar F; Gencer N; Yildirim H; Arslan O
    Biol Pharm Bull; 2006 Aug; 29(8):1559-63. PubMed ID: 16880604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of some antibiotics on human serum paraoxonase 1 activity.
    Dilek EB; Küfrevioğlu Öİ; Beydemir Ş
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):758-64. PubMed ID: 22591317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of heavy metal effects on immobilized paraoxanase by glutaraldehyde.
    Bilen Ç; Beyaztaş S; Arslan O; Güler ÖÖ
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):440-6. PubMed ID: 22233542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of in vitro effect, molecular docking, and molecular dynamics simulations of some dihydropyridine-class calcium channel blockers on human serum paraoxonase 1 (hPON1) enzyme activity.
    Gökçe B; Muhammed MT
    Biotechnol Appl Biochem; 2023 Oct; 70(5):1707-1719. PubMed ID: 37071114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.